Experimental radiation drug for advanced cancers halted early
NCT ID NCT03746431
First seen Nov 01, 2025 · Last updated Jun 14, 2026 · Updated 31 times
Summary
This study tested a new drug that delivers radiation directly to cancer cells in people with advanced solid tumors (like breast, ovarian, or head and neck cancers) that had stopped responding to standard treatments. The goal was to find a safe dose and see if it could shrink tumors. The trial was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Austin Hospital
Heidelberg, Victoria, 3084, Australia
-
Centre Hospitalier De I'Universite de Montreal
Montreal, Quebec, H2X 0C1, Canada
-
City of Hope
Duarte, California, 91010, United States
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
Juravinski Cancer Center - Hamilton Health
Hamilton, Ontario, L8V 5C2, Canada
-
Masonic Cancer Center, University of Minnesota
Minneapolis, Minnesota, 55455, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2C1, Canada
-
Quebec University Hospital- Laval
Québec, Quebec, G1R 2J6, Canada
-
Roswell Park Comprehensive Cancer Center
Buffalo, New York, 14203, United States
-
Royal Adelaide Hospital
Adelaide, South Australia, 5000, Australia
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.